Literature DB >> 10072062

Administration of nitric oxide synthase inhibitors does not alter disease course of amyotrophic lateral sclerosis SOD1 mutant transgenic mice.

M N Upton-Rice, M E Cudkowicz, R K Mathew, D Reif, R H Brown.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072062     DOI: 10.1002/1531-8249(199903)45:3<413::aid-ana24>3.0.co;2-5

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  6 in total

1.  Marked synergism between mutant SOD1 and glutamate transport inhibition in the induction of motor neuronal degeneration in spinal cord slice cultures.

Authors:  Hong Z Yin; John H Weiss
Journal:  Brain Res       Date:  2012-02-09       Impact factor: 3.252

Review 2.  Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.

Authors:  B Halliwell
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 3.  Molecular and cellular pathways of neurodegeneration in motor neurone disease.

Authors:  P J Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

Review 4.  Amyotrophic lateral sclerosis: progress and prospects for treatment.

Authors:  Michel Dib
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice.

Authors:  Kevin Chen; Frances J Northington; Lee J Martin
Journal:  Brain Struct Funct       Date:  2009-11-04       Impact factor: 3.270

6.  Characterization of detergent-insoluble proteins in ALS indicates a causal link between nitrative stress and aggregation in pathogenesis.

Authors:  Manuela Basso; Giuseppina Samengo; Giovanni Nardo; Tania Massignan; Giuseppina D'Alessandro; Silvia Tartari; Lavinia Cantoni; Marianna Marino; Cristina Cheroni; Silvia De Biasi; Maria Teresa Giordana; Michael J Strong; Alvaro G Estevez; Mario Salmona; Caterina Bendotti; Valentina Bonetto
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.